Template File: /srv/users/emquire/apps/emquire2017/public/wp-content/themes/emquire2017/single-project.php | Template Hierarchy
WP version: 6.0
PHP version 7.4.30
Hereditary angioedema is a rare inherited disorder characterized by recurrent episodes of the accumulation of fluids outside of the blood vessels, blocking the normal flow of blood or lymphatic fluid and causing rapid swelling of tissues in the hands, feet, limbs, face, intestinal tract, or airway. Swelling of the gastrointestinal tract leads to cramping. These symptoms develop as the result of deficiency or improper functioning of certain proteins that help to maintain the normal flow of fluids through very small blood vessels (capillaries).
The aim of the EHA trial (Epidemiological Analysis for Hereditary Angioedema Disease) is to identify those patients whose presentations with recurrent abdominal pain may be as a result of this condition. HAE is exceptionally rare and is therefore not often considered as a diagnosis in patients with recurring abdominal pain. This trial therefore aims to assess the feasibility of using a dried blood spot sample in these patients to facilitate diagnosis. The overall objective is that this will prevent both further hospitalisations and further unnecessary investigations on these patients, and also provide answers to those patients who have no current cause for their recurrent issues.
The COVID-19 pandemic has led to unprecedented challenges to healthcare systems across the world. Enquire is contributing to NHS GGC response to this challenge across a range of projects. We have repurposed existing work streams including iCAIRD and TraumaApp with existing collaborators whilst building new relationships to develop solutions that can impact on care delivery. […]
OCTS (Outcomes following Chest Trauma Score) has begun in the QEUH ED! This study aims to measure patient reported outcomes following rib fractures to optimise and improve care of this patient group. The patient will be asked to fill in a questionnaire at time of injury and two follow up questionnaires to assess how […]
Nicola was our first nurse appointed smashing the interview and rapidly getting a handle on the intricacies of clinical research in the ED. Her portfolio of studies includes She leads on Rapid-CTCA, Target-CTCA, SABER and Pro Teds
Mark was appointed in June 2017 and has rapidly found his feet helping promote QEUH ED nurse engagement. His infectious enthusiasm and energy will be a huge asset to the team! He leads on Novel, Aerogen, RAMPP, Frontiers
Introducing Dave the Trauma Man! The QEUH will become a Major Trauma Centre in 2019 as part of the Scottish Trauma Network. Dave is going to have a pretty tough year… in fact he is going to experience more car accidents, falls from height and industrial accidents than any other manikin in Scotland.